🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: The National Cancer Institute (NCI) Surgery Branch has develop...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2014-02-07
Trial ID
NCT02111850
The primary objectives of Phase 1A are to evaluate the safety of KITE-718, ...
Status
Terminated
Location
Banner MD Anderson Cancer Center
Start Date
2017-12-27
Trial ID
NCT03139370
Treatments Being Tested
The overall purpose of this research study is to find a better way to treat...
Status
Terminated
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2011-10-11
Trial ID
NCT01437605
Treatments Being Tested
The goal of this clinical research study is to learn if the drug leuprolide...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2005-11
Trial ID
NCT00254397
Treatments Being Tested
The hope is that the peptide vaccines will stimulate the immune system to a...
Status
Completed
Location
University of Arkansas for Medical Sciences/MIRT
Start Date
2004-06
Trial ID
NCT00090493
Treatments Being Tested
Gastric cancer is one of the leading causes of cancer-related deaths worldw...
Status
Suspended
Location
Multiple Locations
Start Date
2010-03
Trial ID
NCT02686424
The purpose of this clinical trial is to evaluate the benefit of the immuno...
Status
Terminated
Location
GSK Investigational Site
Start Date
2008-12-01
Trial ID
NCT00796445
Treatments Being Tested
The goals of this study are to 1) assess the safety of recombinant MAGE-A3 ...
Status
Completed
Location
University of Virginia
Start Date
2011-06
Trial ID
NCT01425749
Treatments Being Tested
RATIONALE: Vaccines made from peptides may help the body build an effective...
Status
Terminated
Location
University of Virginia Cancer Center
Start Date
2006-04-13
Trial ID
NCT00373217
This is a Phase 1b open-label dose escalation trial of Ad/MG1-MAGEA3 and Pe...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-02-15
Trial ID
NCT03773744
Treatments Being Tested